Imcivree

Rhythm Pharmaceuticals

Setmelanotide is used to treat rare genetic forms of obesity caused by specific mutations in genes that control appetite and metabolism. It helps reduce weight and food cravings in people with these genetic conditions.[2] Imcivree is currently approved and in use across 6 indications[4].[1]

Imcivree is one of 81 peptide programs targeting Prader-Willi syndrome. It is currently in Approved.